Montelukast as an effective adjuvant in the treatment of moderate acne vulgaris. Issue 10 (29th August 2022)
- Record Type:
- Journal Article
- Title:
- Montelukast as an effective adjuvant in the treatment of moderate acne vulgaris. Issue 10 (29th August 2022)
- Main Title:
- Montelukast as an effective adjuvant in the treatment of moderate acne vulgaris
- Authors:
- Fazelzadeh Haghighi, Negin
Dastgheib, Ladan
Saki, Nasrin
Alipour, Shohreh
Ranjbar, Sara - Abstract:
- Abstract: Although antibiotics are among the most commonly used treatments of acne, there are refractory cases, or they can cause some complications. Recently, leukotriene B4 has been found to play a major role in inflammatory acne lesions. This double blind, randomized clinical trial was conducted on 108 patients with acne who needed systemic therapy and referred to dermatology clinics affiliated to Shiraz University of Medical Sciences. One group (53 patients) received 100 mg doxycycline daily plus placebo and the other group (55 patients) received 100 mg daily doxycycline plus 10 mg daily montelukast. Both groups also received topical benzoyl peroxide 5% every other night. The study period was 3 months and the patients were investigated by lesion count, investigator global assessment (IGA), global acne grading system (GAGS), and Cardiff acne disability index (CADI) scoring systems. Total lesion count, inflammatory lesion count, and non‐inflammatory lesion count as well as IGA and GAGS decreased in both treatment groups. At the end of the study, however, the inflammatory lesion count and IGA score reduced more significantly in the montelukast group ( p = 0.018 and 0.045, respectively). In addition, the two groups were significantly different with regard to the percentage of decrease in the total lesion count, inflammatory lesions, and IGA ( p = 0.033, 0.003, and 0.044, respectively). Thus, montelukast can be used as an adjuvant therapy besides other treatments of acne,Abstract: Although antibiotics are among the most commonly used treatments of acne, there are refractory cases, or they can cause some complications. Recently, leukotriene B4 has been found to play a major role in inflammatory acne lesions. This double blind, randomized clinical trial was conducted on 108 patients with acne who needed systemic therapy and referred to dermatology clinics affiliated to Shiraz University of Medical Sciences. One group (53 patients) received 100 mg doxycycline daily plus placebo and the other group (55 patients) received 100 mg daily doxycycline plus 10 mg daily montelukast. Both groups also received topical benzoyl peroxide 5% every other night. The study period was 3 months and the patients were investigated by lesion count, investigator global assessment (IGA), global acne grading system (GAGS), and Cardiff acne disability index (CADI) scoring systems. Total lesion count, inflammatory lesion count, and non‐inflammatory lesion count as well as IGA and GAGS decreased in both treatment groups. At the end of the study, however, the inflammatory lesion count and IGA score reduced more significantly in the montelukast group ( p = 0.018 and 0.045, respectively). In addition, the two groups were significantly different with regard to the percentage of decrease in the total lesion count, inflammatory lesions, and IGA ( p = 0.033, 0.003, and 0.044, respectively). Thus, montelukast can be used as an adjuvant therapy besides other treatments of acne, especially for inflammatory lesions. … (more)
- Is Part Of:
- Dermatologic therapy. Volume 35:Issue 10(2022)
- Journal:
- Dermatologic therapy
- Issue:
- Volume 35:Issue 10(2022)
- Issue Display:
- Volume 35, Issue 10 (2022)
- Year:
- 2022
- Volume:
- 35
- Issue:
- 10
- Issue Sort Value:
- 2022-0035-0010-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2022-08-29
- Subjects:
- acne -- adjuvant -- doxycycline -- montelukast -- treatment
Skin -- Diseases -- Periodicals
Dermatology -- Periodicals
616.5 - Journal URLs:
- http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=1396-0296;screen=info;ECOIP ↗
http://onlinelibrary.wiley.com/journal/10.1111/%28ISSN%291529-8019 ↗
http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=dth ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/dth.15770 ↗
- Languages:
- English
- ISSNs:
- 1396-0296
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3555.143000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24024.xml